ACCOUNTS - Final Accounts preparation

Company registration number: 14981224

	UNAUDITED FINANCIAL STATEMENTS
	FOR THE YEAR ENDED 30 JUNE 2025

	NOVARI HEALTH UK LIMITED


NOVARI HEALTH UK LIMITED

COMPANY INFORMATION

Directors	J Lott (resigned 4 July 2025)
	J Sinclair (resigned 4 July 2025)
	B Goffenberg (appointed 4 July 2025)
	D Matlow (appointed 4 July 2025)
	M Sanders (appointed 4 July 2025)


Registered number	14981224


Registered office	C/O Edwin Coe Llp
	2 Stone Buildings
	London
	WC2A 3TH


Accountants	Menzies LLP
	Chartered Accountants
	4th Floor
	95 Gresham Street
	London
	EC2V 7AB


NOVARI HEALTH UK LIMITED

CONTENTS

	Page
Statement of financial position	1
Notes to the financial statements	2 - 4


NOVARI HEALTH UK LIMITED REGISTERED NUMBER:14981224

STATEMENT OF FINANCIAL POSITION

AS AT 30 JUNE 2025

		2025		2024
Note		£		£


Current assets
Debtors: amounts falling due within one year	4	68,400		32,743
Cash at bank and in hand		2,240		5,796
		70,640		38,539
Creditors: amounts falling due within one year	5	(22,715)		(28,401)
Net current assets			47,925		10,138
Total assets less current liabilities			47,925		10,138

Net assets			47,925		10,138

Capital and reserves
Called up share capital	1	1
Profit and loss account	47,924	10,137
	47,925	10,138

The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by:

M Sanders

Director

Date: 27 August 2025

The notes on pages 2 to 4 form part of these financial statements.

Page 1


NOVARI HEALTH UK LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 JUNE 2025

1.	General information

Novari Health UK Limited is a private company, limited by shares, registered in England and Wales, with company registration number 14981224. The registered office is stated on the company information page. There is no principal place of business.

2.Accounting policies

2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

2.2

Foreign currency translation

Functional and presentation currency

The Company's functional and presentational currency is GBP.

Transactions and balances

Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions.

At each period end foreign currency monetary items are translated using the closing rate. Non-monetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined.

2.3

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:

∙the amount of revenue can be measured reliably;

∙it is probable that the Company will receive the consideration due under the contract;

∙the stage of completion of the contract at the end of the reporting period can be measured reliably; and

∙the costs incurred and the costs to complete the contract can be measured reliably.

Page 2


NOVARI HEALTH UK LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 JUNE 2025

2.Accounting policies (continued)

2.4

Pensions

Defined contribution pension plan

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Statement of financial position. The assets of the plan are held separately from the Company in independently administered funds.

2.5

Taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the Company operates and generates income.

2.6

Financial instruments

The Company has elected to apply the provisions of Section 11 “Basic Financial Instruments” of FRS 102 to all of its financial instruments.

Employees

The average monthly number of employees, including directors, during the year was 3 (2024 - 3).

Page 3


NOVARI HEALTH UK LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 JUNE 2025

Debtors

					2025	2024
					£	£


Other debtors	34,683	19,810
Prepayments and accrued income	33,717	12,933
	68,400	32,743

5.	Creditors: Amounts falling due within one year
		2025	2024
		£	£

Trade creditors	223	20,988
Corporation tax	12,596	2,663
Other creditors	2,661	-
Accruals and deferred income	7,235	4,750
	22,715	28,401

6.	Controlling party

The ultimate controlling party during the year was Novari Health Inc located at 1473 John Counter, Boulevard Suite 401, Kingston,Canada, K7M 8Z6
Subsequent to the year end, the company was acquired and the ultimate controlling party is now Vitalhub Corp located at Suite 1001, 480 University Avenue, Toronto, Ontario, Canada, M5G 1V2.

Page 4